Integrimedical Profile
Key Indicators
- Authorised Capital ₹ 4.54 Cr
- Paid Up Capital ₹ 3.63 Cr
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 675810.45%
- Profit Growth -20.24%
- Ebitda -211.58%
- Net Worth 4328.46%
- Total Assets 900.08%
About Integrimedical
Integrimedical Private Limited (IPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2020 (Four years and seven months 28 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.54 Cr and a paid-up capital of Rs 3.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sarvesh Mutha, Ankur Naik, Mark Timm, and One other member serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33309PN2020PTC191483
- Company No.
191483
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Integrimedical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarvesh Mutha  | Director | 25-Jun-2020 | Current |
| Ankur Naik | Director | 25-Jun-2020 | Current |
Mark Timm  | Director | 24-Sep-2020 | Current |
| Scott Mcfarland | Director | 24-Sep-2020 | Current |
Financial Performance of Integrimedical.
Integrimedical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 675810.45% increase. The company also saw a substantial fall in profitability, with a 20.24% decrease in profit. The company's net worth Soared by an impressive increase of 4328.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integrimedical?
In 2023, Integrimedical had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
I-Ziel Solutions Private LimitedSarvesh Mutha is a mutual person
Iziel Healthcare LlpSarvesh Mutha and Ankur Naik are mutual person
Iziel Products LlpSarvesh Mutha and Ankur Naik are mutual person
- Iziel Services Llp
Sarvesh Mutha and Ankur Naik are mutual person
- Iziel Software Solutions Llp
Sarvesh Mutha and Ankur Naik are mutual person
- Mutha Textiles Pvt Ltd
Sarvesh Mutha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Integrimedical?
Integrimedical has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrimedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrimedical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.